Gender [male (%)] | 63 | 57 |
Age (years ± SD) | 64 ± 12.2 | 64 ± 11.9 |
ASA (%) | | |
I | 41.8 | 37.1 |
II | 37.3 | 37.1 |
III | 20.9 | 25.7 |
Lymphadenectomy (%) | | |
D1 | 19.2 | 23.9 |
D2 | 80.8 | 76.1 |
Tumou r site (%) | | |
Lesser curvature | 33.3 | 38.6 |
Greater curvature | 38.9 | 40.4 |
Anterior wall | 25.0 | 15.8 |
Posterior wall | 1.4 | 2.6 |
Circumferential | 1.4 | 2.6 |
Differentiation (%) | | |
Well | 27.4 | 21.0 |
Moderate | 25.8 | 33.0 |
Poor | 46.8 | 46.0 |
Lauren (%) | | |
Intestinal | 63.9 | 47.2 |
Diffuse | 19.7 | 31.5 |
Mixed | 16.4 | 21.3 |
Lymphangial invasion [yes (%)] | 52.9 | 54.7 |
Vascular invasion[yes (%)] | 7.3 | 11.1 |
Perineural invasion[yes (%)] | 15.7 | 14.4 |
T stage (%) | | |
1 | 31.5 | 43.8 |
2 | 38.4 | 28.9 |
3 | 26.0 | 18.4 |
4 | 4.1 | 8.8 |
UICC (%) | | |
Ia | 31.5 | 45.6 |
Ib | 38.4 | 28.9 |
IIa | 26.0 | 16.7 |
IIb | 1.4 | 5.3 |
IIIb | 2.7 | 3.5 |
Tumour diameter (mm ± SD) | 52 ± 33.8 | 50 ± 32.4 |
Number of extractedlymph nodes (n ± SD) | 21 ± 11.2 | 20 ± 10.7 |